Parkinson’s Researcher Notches 17 Retracted Papers

Scientific misconduct motivated Yoshihiro Sato’s three additional retractions last month; his institution doesn’t respond.

Written byAggie Mika
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ISTOCK, ALLANSWARTUpdate (December 7, 2017): According to Retraction Watch, Sato’s retraction count is now up to 23 and Hirosaki University, where Sato was based from 2000 to 2003, confirmed in November that a number of Sato’s papers were compromised by fake data, plagiarism, or authorship issues.

Yoshihiro Sato, a researcher from Mitate Hospital in Tagawa, Japan, cited scientific wrongdoing when he asked the Journal of Neurology, Neurosurgery, and Psychiatry to pull three of his publications, adding to his list of 14 prior retractions, Retraction Watch reports.

The journal announced its investigation in May and retracted Sato’s three papers last month. According to the retraction notices, Sato told the journal editors that he didn’t have his coauthors’ permission to include them on the papers and that the authors in question didn’t contribute to the published science.

“Despite repeated requests for further explanation, we have not received any response from Dr Sato’s institution,” read the journal’s retraction notices.

The now-disputed research involves randomized human studies testing various therapeutics for ailments associated with Parkinson’s ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies